Get 30% off on all global market reports with code ONLINE30 – stay updated on tariff changes, macroeconomic trends, and more!
What’s Behind the Strong Growth of the Stem Cell Umbilical Cord Blood Market Size in the Last 5 Years?
The market size for stem cell umbilical cord blood has experienced swift expansion over the past few years. The market valuation is projected to escalate from $6.77 billion in 2024 to $7.98 billion in 2025, registering a compound annual growth rate (CAGR) of 17.8%. This growth during the historical era is due to factors such as augmented research and development, growing demand for private banking facilities, an increase in clinical trials, a rise in cancer cases, and the expansion of fertility clinics.
There is a prediction for rapid expansion in the stem cell umbilical cord blood market in the coming years. This market is projected to soar to $15.21 billion by 2029, with a compound annual growth rate (CAGR) of 17.5%. The factors contributing to this uptick in the forecast period could be the rise in chronic illnesses, growth in birth rates, surging demand for stem cell treatments, favorable governmental policies and programs, as well as an increased focus on restorative medicine. The forecast period is also characterised by significant progress in therapeutic applications, advanced medical infrastructure, improvements in cryopreservation methods, and synergies with gene therapy.
Claim Your Free Sample Report:
http://www.thebusinessresearchcompany.com/sample….p;type=smp
What Drivers Are Powering the Rise of the Stem Cell Umbilical Cord Blood Market?
The stem cell umbilical cord blood market’s growth is set to be fueled by the increasing rates of childbirth. The term ‘childbirth rates’ is used to denote the number of live births per 1,000 individuals within a certain population, typically measured over a one year period. This rise in childbirth rates can be attributed to the increased accessibility and affordability of fertility treatments, thus enabling a greater number of families to have children.
As they carry hematopoietic stem cells, umbilical cord blood stem cells are incredibly beneficial for newborns, with the potential to treat a variety of blood, immune, and genetic conditions. These cells, which are a precise genetic match for the baby, could be beneficial to siblings or family members. As evidence, in April 2025, data from the U.S. Centers for Disease Control and Prevention, a U.S. federal agency, showed a rise in American births from 3,596,017 in 2023 to 3,622,673 in 2024, a growth of 1%. Thus, it is the increasing rate of childbirth that is aiding in the expansion of the stem cell umbilical cord blood market.
How Is the Stem Cell Umbilical Cord Blood Market Structured Across Key Segments?
The stem cell umbilical cord blood market covered in this report is segmented –
1) By Product Type: Cord Blood Stem Cells, Cord Tissue Stem Cells
2) By Technology: Cryopreservation, Stem Cell Expansion, Cell Separation
3) By Storage Services: Public Cord Blood Banks, Private Cord Blood Banks, Hybrid Cord Blood Banks
4) By Application: Hematological Disorders, Metabolic Diseases, Immune System Disorders, Neurological Disorders, Other Applications
5) By End-User: Hospitals, Research Institutes, Biotechnology Companies, Other End-Users
Subsegments:
1) By Cord Blood Stem Cells: Hematopoietic Stem Cells, Mesenchymal Stem Cells, Endothelial Progenitor Cells, Regulatory T Cells, Natural Killer Cells, Dendritic Cells
2) By Cord Tissue Stem Cells: Mesenchymal Stem Cells, Epithelial Cells, Fibroblasts, Neural Progenitor Cells
Access the Full Report Today:
http://www.thebusinessresearchcompany.com/report/…ket-report
How Will Market Trends Drive Strategic Shifts in the Stem Cell Umbilical Cord Blood Sector?
Leading enterprises operating in the stem cell umbilical cord blood sector are prioritizing the development of innovative treatments and securing necessary approvals. A key focus area for them is cord blood cell therapy, a method that leverages stem cells from umbilical cord blood to battle rare genetic disorders, bolster immune system recovery, and assist in regenerative medicine applications. This therapy aims to treat various diseases through the regeneration or repair of damaged blood, immune, and other tissue systems. For example, in October 2024, StemCyte, an American biotech firm, was granted the regenerative medicine advanced therapy designation by the U.S. Food and Drug Administration (FDA) for its hematopoietic progenitor cell cord blood therapy (HPC Cord Blood) used in treating Long COVID-19 syndrome. This therapy harnesses stem cells from umbilical cord blood to encourage healing and reduce inflammation, showing promise in the treatment of immune-related and degenerative conditions. It is an ethically sourced, non-invasive option for advanced regenerative treatments.
Where Is the Stem Cell Umbilical Cord Blood Market Experiencing the Fastest Regional Growth?
North America was the largest region in the stem cell umbilical cord blood market in 2024. Europe is expected to be the fastest-growing region in the forecast period. The regions covered in the stem cell umbilical cord blood market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Get a Customized Version of the Report:
http://www.thebusinessresearchcompany.com/customi…p;type=smp
Leading Players Shaping the Future of the Stem Cell Umbilical Cord Blood Industry
Major companies operating in the stem cell umbilical cord blood market are Takeda Pharmaceutical Company Limited, Global Cord Blood Corporation, Vita 34 AG, Cordlife Group Limited, StemLife Berhad, MediPost Co. Ltd., Smart Cells International Ltd., StemCyte Inc., Celularity Inc., Next Biosciences Pty Ltd, Esperite N.V., Cryo-Cell International Inc., FamiCord Group, Cells4Life Group LLP, Cryoviva Biotech Pvt. Ltd., Americord Registry LLC, ViaCord LLC, China Cord Blood Corporation, CBR Systems Inc., Cord Blood Registry.
Access the Complete Report:
http://www.thebusinessresearchcompany.com/purchas…x?id=24715
How Our Market Research Reports Help Maximize ROI Across Industries:
* Identify High-Growth Opportunities: Pinpoint emerging trends, untapped segments, and regional hotspots that align with your strategic goals.
* Reduce Investment Risk: Make data-driven decisions with confidence by understanding market dynamics, key drivers, and competitive threats.
* Optimize Strategic Planning: Align your product development, marketing, and expansion plans with industry forecasts and customer behaviour insights.
Americas +1 310-496-7795
Asia +44 2071930708
Europe +44 7882 955267
News From
The Business Research Company …
Category: Industry Reports & Market Analysis Profile: The Business Research Company is a leading market research and consulting services provider. It offers over 9,500 market reports across 27 industries in 60+ geographies, providing detailed insights and forecasts. Its customised research solutions support companies in making critical decisions, while its continuous research service enhances organizational capabilities. The flagship Global Market Model database provides comprehensive market intelligence with 1,500,000 datasets covering 8,000+ mark …
This email address is being protected from spambots. You need JavaScript enabled to view it.
For more information:
http://www.thebusinessresearchcompany.com/report/…ket-report
